author-photo

David Ghez

Institut Gustave Roussy

32

Papers

219

Citations

Citation Trend

Filter By

Papers (24) Sort By

Journal Conference Others

Innovative therapies based on molecular orientation in patients with relapse and refractory diffuse large B-cell lymphoma: Results of LNH-EP1 study.

2021 American Journal of Hematology
Show All
- Source
- Cite
- Save
Citations (0)
Impact of age, functional status, and comorbidities on quality of life and outcomes in elderly patients with AML: review.

2021 Annals of Hematology
Show All
- Source
- Cite
- Save
Citations (0)
Blastic plasmacytoid dendritic cell neoplasms: results of an international survey on 398 adult patients.

2020 Blood Advances
Show All
- Source
- Cite
- Save
Citations (11)
Azacytidine in combination with tyrosine kinase inhibitors induced durable responses in patients with advanced phase chronic myelogenous leukemia

2018 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (7)
Outcome of chronic lymphocytic leukemia patients who switched from either ibrutinib or idelalisib to alternate kinase inhibitor: A retrospective study of the French innovative leukemia organization (FILO)

2018 American Journal of Hematology
Show All
- Source
- Cite
- Save
Citations (1)
The Impact of Risk-Adapted Treatment Strategy on Outcome of Patients with Acute Myeloid Leukemia Aged ≥ 60 Years after Allogeneic Stem Cell Transplantation

2017 Blood
Show All
- Source
- Cite
- Save
Citations (0)
First-line escalated BEACOPP does not hinder stem cell collection and transplantation strategy in patients with relapsed/refractory Hodgkin’s lymphoma

2017 Bone Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (1)
Ibrutinib in very elderly patients with relapsed/refractory chronic lymphocytic leukemia: A real-world experience of 71 patients treated in France A study from the French Innovative Leukemia Organization (FILO) group

2017 American Journal of Hematology
Show All
- Source
- Cite
- Save
Citations (7)
Single or tandem autologous stem-cell transplantation for first-relapsed or refractory Hodgkin lymphoma: 10-year follow-up of the prospective H96 trial by the LYSA/SFGM-TC study group

2016 Haematologica
Show All
- Source
- Cite
- Save
Citations (31)
STEM CELL COLLECTION AFTER FAILURE OF UPFRONT ABVD OR BEACOPP IN PATIENTS WITH HIGH RISK ADVANCED STAGE III-IV HODGKIN'S LYMPHOMA

2016 Haematologica
Show All
- Source
- Cite
- Save
Citations (5)